Heart Disease Trial, Recruiting NCT03951467 Sponsor: Hospices Civils de Lyon Condition: Heart Disease
Back to Heart Disease

Heart Disease Trial, Recruiting

NCT03951467
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have been hospitalised for at least a second acute episode of heart failure (either involving the upper or lower blood pressure reading)
  • People who were living at home before being hospitalised for this episode
  • People who are covered by a health insurance plan

Who may not be able to join:

  • People whose life is considered to be at short-term risk (confirm with trial site)
  • People with bipolar disorder or active psychosis
  • People with severe dementia
  • People with psychiatric or cognitive conditions that the investigator determines would make participation impossible
  • Women who are pregnant, in labour, or breastfeeding
  • People who are currently deprived of their liberty by a court or administrative decision
  • People who are staying in a health or social care facility for reasons other than research
  • Adults who are under a legal protection measure, such as guardianship or curatorship
  • People who are currently taking part in another interventional research study that has an exclusion period still in effect
  • People who score above 22 on the S-TOFHLA, a test that measures health literacy (confirm with trial site)
  • People who have withdrawn their consent to participate

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 16 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Julie HAESEBAERT, MD, Hospices Civils de Lyon

Phone: 04 72 68 49 05

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
26 June 2025
Est. completion
26 December 2027

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Patient-related medication errors or misuse within 30 days of discharge from hospital.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov